Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 9, 2013 - Issue 7
Submit an article Journal homepage
176
Views
11
CrossRef citations to date
0
Altmetric
Drug Profile

Update on the use of abatacept for the treatment of rheumatoid arthritis

Esther F Vicente Rabaneda Rheumatology Department, Hospital Universitario de La Princesa, IIS-Princesa, Universidad Autónoma de Madrid, C/ Diego de León 62, 28006 Madrid, Spain; Rheumatology Department, Hospital Universitario de La Princesa, IIS-Princesa, Universidad Autónoma de Madrid, C/ Diego de León 62, 28006 Madrid, Spain
,
Gabriel Herrero-Beaumont Bone and Joint Research Unit, Service of Rheumatology, IIS Fundación Jiménez Díaz, Universidad Autónoma de Madrid, C Av. Reyes Católicos 2, 28040 Madrid, Spain; Bone and Joint Research Unit, Service of Rheumatology, IIS Fundación Jiménez Díaz, Universidad Autónoma de Madrid, C Av. Reyes Católicos 2, 28040 Madrid, Spain
&
Santos Castañeda Rheumatology Department, Hospital Universitario de La Princesa, IIS-Princesa, Universidad Autónoma de Madrid, C/ Diego de León 62, 28006 Madrid, Spain. [email protected]; Rheumatology Department, Hospital Universitario de La Princesa, IIS-Princesa, Universidad Autónoma de Madrid, C/ Diego de León 62, 28006 Madrid, Spain. [email protected]
Pages 599-621 | Published online: 10 Jan 2014

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Victor R. Pimentel-Quiroz, Manuel F. Ugarte-Gil & Graciela S. Alarcón. (2016) Abatacept for the treatment of systemic lupus erythematosus. Expert Opinion on Investigational Drugs 25:4, pages 493-499.
Read now
Jacqueline Detert & Pascal Klaus. (2015) Biologic monotherapy in the treatment of rheumatoid arthritis. Biologics: Targets and Therapy 9, pages 35-43.
Read now
Xi Xie, David Zhang, Jin-wei Chen, Jing Tian, Guang-hui Ling & Fen Li. (2014) Pharmacogenomics of biological treatment in rheumatoid arthritis. Expert Opinion on Biological Therapy 14:2, pages 157-164.
Read now

Articles from other publishers (8)

Marcela HerreraMagnus SöderbergAlan SabirshBarbara ValastroJohan MölneBeatriz Santamaria, Angela M. Valverde, Silvia GuionaudStephanie HeasmanAlison Bigley, Lutz JermutusCristina RondinoneMatthew CoghlanDavid BakerCarol Moreno Quinn. (2017) Inhibition of T-cell activation by the CTLA4-Fc Abatacept is sufficient to ameliorate proteinuric kidney disease. American Journal of Physiology-Renal Physiology 312:4, pages F748-F759.
Crossref
Ennio Lubrano & Fabio Massimo Perrotta. (2016) Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis. Drugs 76:6, pages 663-673.
Crossref
Kevin D. Pile, Garry G. Graham & Stephen M. Mahler. 2016. Compendium of Inflammatory Diseases. Compendium of Inflammatory Diseases 271 274 .
Kevin D. Pile, Garry G. Graham & Stephen M. Mahler. 2016. Encyclopedia of Inflammatory Diseases. Encyclopedia of Inflammatory Diseases 1 4 .
Hubert G. Nüßlein, Rieke Alten, Mauro Galeazzi, Hanns-Martin Lorenz, Michael T. Nurmohamed, William G. Bensen, Gerd R. Burmester, Hans-Hartmut Peter, Karel Pavelka, Melanie Chartier, Coralie Poncet, Christiane Rauch & Manuela Le Bars. (2015) Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study. BMC Musculoskeletal Disorders 16:1.
Crossref
Kevin D. Pile, Garry G. Graham & Stephen M. Mahler. 2015. Encyclopedia of Inflammatory Diseases. Encyclopedia of Inflammatory Diseases 1 4 .
Charles J Malemud. (2014) Protein kinase small molecule inhibitors for rheumatoid arthritis: Medicinal chemistry/clinical perspectives. World Journal of Orthopedics 5:4, pages 496.
Crossref
Robin Christensen, Simon Tarp, Daniel E Furst, Lars E Kristensen & Henning Bliddal. (2013) Efficacy and safety of infliximab or adalimumab, versus abatacept, in patients with rheumatoid arthritis: ATTEST–AMPLE network randomized trial. International Journal of Clinical Rheumatology 8:6, pages 647-655.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.